NO176125C - Fremgangsmåte for fremstilling av granulater for orale multipartikkelblandinger med kontrollert frigjöring - Google Patents
Fremgangsmåte for fremstilling av granulater for orale multipartikkelblandinger med kontrollert frigjöringInfo
- Publication number
- NO176125C NO176125C NO895114A NO895114A NO176125C NO 176125 C NO176125 C NO 176125C NO 895114 A NO895114 A NO 895114A NO 895114 A NO895114 A NO 895114A NO 176125 C NO176125 C NO 176125C
- Authority
- NO
- Norway
- Prior art keywords
- multiparticle
- compositions
- controlled release
- release oral
- preparing granules
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP88202983 | 1988-12-20 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO895114D0 NO895114D0 (no) | 1989-12-19 |
| NO895114L NO895114L (no) | 1990-06-21 |
| NO176125B NO176125B (no) | 1994-10-31 |
| NO176125C true NO176125C (no) | 1995-02-08 |
Family
ID=8199893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO895114A NO176125C (no) | 1988-12-20 | 1989-12-19 | Fremgangsmåte for fremstilling av granulater for orale multipartikkelblandinger med kontrollert frigjöring |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0375063B1 (no) |
| JP (1) | JPH02223513A (no) |
| KR (1) | KR900009059A (no) |
| CN (1) | CN1044398A (no) |
| AU (1) | AU622745B2 (no) |
| CA (1) | CA2005992A1 (no) |
| DE (1) | DE68909023T2 (no) |
| DK (1) | DK647689A (no) |
| ES (1) | ES2059710T3 (no) |
| FI (1) | FI896062A0 (no) |
| HU (1) | HU203279B (no) |
| IL (1) | IL92343A0 (no) |
| NO (1) | NO176125C (no) |
| NZ (1) | NZ231828A (no) |
| PT (1) | PT92616B (no) |
| ZA (1) | ZA899732B (no) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5776493A (en) * | 1989-07-14 | 1998-07-07 | Alza Corporation | Oral osmotic device for delivery of nystatin with hydrogel driving member |
| GB2253346A (en) * | 1991-02-22 | 1992-09-09 | John Rhodes | Delayed release oral dosage forms for treatment of intestinal disorders |
| TW212139B (no) * | 1991-04-15 | 1993-09-01 | Yamanouchi Pharma Co Ltd | |
| AU1537292A (en) * | 1991-04-16 | 1992-11-17 | Nippon Shinyaku Co. Ltd. | Method of manufacturing solid dispersion |
| US5248310A (en) * | 1992-03-27 | 1993-09-28 | Alza Corporation | Oral osmotic device with hydrogel driving member |
| US5512299A (en) * | 1992-03-30 | 1996-04-30 | Alza Corporation | Method of treating oral inflammatory disease |
| WO1995016451A1 (fr) * | 1992-06-22 | 1995-06-22 | Franck Arno Gouchet | Comprimes a liberation controlee de 4-asa |
| FR2692484B1 (fr) * | 1992-06-22 | 1995-06-30 | Gouchet Franck | Nouvelle forme galenique de 4-asa a liberation controlee. |
| US5395627A (en) * | 1992-09-04 | 1995-03-07 | Akzo N.V. | Pharmaceutical granulate |
| US5573776A (en) * | 1992-12-02 | 1996-11-12 | Alza Corporation | Oral osmotic device with hydrogel driving member |
| US6426085B1 (en) | 1994-05-02 | 2002-07-30 | Josman Laboratories Inc. | Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis |
| US5834002A (en) | 1994-05-02 | 1998-11-10 | Josman Laboratories, Inc. | Chewing gum containing colloidal bismuth subcitrate |
| US6902738B2 (en) | 1994-05-02 | 2005-06-07 | Josman Laboratories, Inc. | Topical oral dosage forms containing bismuth compounds |
| AT403988B (de) * | 1994-05-18 | 1998-07-27 | Lannacher Heilmittel | Festes orales retardpräparat |
| GB9422154D0 (en) | 1994-11-03 | 1994-12-21 | Euro Celtique Sa | Pharmaceutical compositions and method of producing the same |
| US5965161A (en) | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
| US6372784B1 (en) | 1995-02-07 | 2002-04-16 | Josman Laboratories, Inc. | Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds |
| US6379651B1 (en) | 1995-02-07 | 2002-04-30 | Josman Laboratories | Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases |
| IT1301947B1 (it) * | 1998-07-28 | 2000-07-20 | Chiesi Farma Spa | Formulazioni farmaceutiche di beclometasone dipropionato per iltrattamento di malattie infiammatorie croniche della mucosa |
| DE19918325A1 (de) | 1999-04-22 | 2000-10-26 | Euro Celtique Sa | Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion |
| US8895064B2 (en) | 1999-06-14 | 2014-11-25 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
| ATE251449T1 (de) | 1999-06-14 | 2003-10-15 | Cosmo Spa | Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe |
| ITMI991316A1 (it) * | 1999-06-14 | 2000-12-14 | Cip Ninety Two 92 S A | Composizioni farmaceutiche orali a rilascio modificato di mesalazina |
| JP4310605B2 (ja) * | 2001-05-25 | 2009-08-12 | 大塚製薬株式会社 | 医薬用組成物 |
| US20030190343A1 (en) * | 2002-03-05 | 2003-10-09 | Pfizer Inc. | Palatable pharmaceutical compositions for companion animals |
| US8840928B2 (en) | 2002-07-05 | 2014-09-23 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
| JP4694207B2 (ja) * | 2002-07-05 | 2011-06-08 | コルジウム ファーマシューティカル， インコーポレイテッド | オピオイドおよび他の薬物に関する乱用抑止性の薬学的組成物 |
| US10004729B2 (en) | 2002-07-05 | 2018-06-26 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
| US8557291B2 (en) | 2002-07-05 | 2013-10-15 | Collegium Pharmaceutical, Inc. | Abuse-deterrent pharmaceutical compositions of opioids and other drugs |
| SI1765292T1 (en) | 2004-06-12 | 2018-04-30 | Collegium Pharmaceutical, Inc. | Formulations of medicines to discourage abuse |
| US20070048373A1 (en) * | 2005-08-30 | 2007-03-01 | Cima Labs Inc. | Dried milled granulate and methods |
| US10668060B2 (en) | 2009-12-10 | 2020-06-02 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
| WO2011101734A2 (en) * | 2010-02-22 | 2011-08-25 | Lupin Limited | Taste-masked powder for suspension compositions of methylprednisolone |
| IT1405012B1 (it) * | 2010-08-06 | 2013-12-16 | Sofar Spa | Composizioni di beclometasone dipropionato in microsfere gastroresistenti a rilascio modificato e processo per il loro ottenimento |
| US10154964B2 (en) | 2011-09-07 | 2018-12-18 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
| US9737530B1 (en) | 2016-06-23 | 2017-08-22 | Collegium Pharmaceutical, Inc. | Process of making stable abuse-deterrent oral formulations |
-
1989
- 1989-11-17 IL IL92343A patent/IL92343A0/xx not_active IP Right Cessation
- 1989-12-12 KR KR1019890018375A patent/KR900009059A/ko not_active Application Discontinuation
- 1989-12-18 NZ NZ231828A patent/NZ231828A/en unknown
- 1989-12-18 FI FI896062A patent/FI896062A0/fi not_active IP Right Cessation
- 1989-12-18 DE DE89203243T patent/DE68909023T2/de not_active Expired - Fee Related
- 1989-12-18 ES ES89203243T patent/ES2059710T3/es not_active Expired - Lifetime
- 1989-12-18 EP EP89203243A patent/EP0375063B1/en not_active Expired - Lifetime
- 1989-12-19 ZA ZA899732A patent/ZA899732B/xx unknown
- 1989-12-19 JP JP1329380A patent/JPH02223513A/ja active Pending
- 1989-12-19 PT PT92616A patent/PT92616B/pt not_active IP Right Cessation
- 1989-12-19 CN CN89109394A patent/CN1044398A/zh active Pending
- 1989-12-19 DK DK647689A patent/DK647689A/da not_active Application Discontinuation
- 1989-12-19 CA CA002005992A patent/CA2005992A1/en not_active Abandoned
- 1989-12-19 NO NO895114A patent/NO176125C/no unknown
- 1989-12-19 HU HU896686A patent/HU203279B/hu not_active IP Right Cessation
- 1989-12-20 AU AU47131/89A patent/AU622745B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| NO176125B (no) | 1994-10-31 |
| AU4713189A (en) | 1990-06-28 |
| NO895114D0 (no) | 1989-12-19 |
| NO895114L (no) | 1990-06-21 |
| HU203279B (en) | 1991-07-29 |
| KR900009059A (ko) | 1990-07-02 |
| AU622745B2 (en) | 1992-04-16 |
| CA2005992A1 (en) | 1990-06-20 |
| HU896686D0 (en) | 1990-02-28 |
| CN1044398A (zh) | 1990-08-08 |
| DK647689A (da) | 1990-06-21 |
| ES2059710T3 (es) | 1994-11-16 |
| PT92616A (pt) | 1990-06-29 |
| IL92343A0 (en) | 1990-07-26 |
| EP0375063B1 (en) | 1993-09-08 |
| DE68909023D1 (de) | 1993-10-14 |
| FI896062A0 (fi) | 1989-12-18 |
| DK647689D0 (da) | 1989-12-19 |
| DE68909023T2 (de) | 1994-02-03 |
| PT92616B (pt) | 1995-09-12 |
| ZA899732B (en) | 1990-09-26 |
| EP0375063A1 (en) | 1990-06-27 |
| NZ231828A (en) | 1992-03-26 |
| JPH02223513A (ja) | 1990-09-05 |
| HUT53514A (en) | 1990-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO176125C (no) | Fremgangsmåte for fremstilling av granulater for orale multipartikkelblandinger med kontrollert frigjöring | |
| NO884408D0 (no) | Kontrollerte frigjoeringsformuleringer av tetracyklinforbindelser. | |
| IL72565A (en) | Fast release pharmaceutical composition containing isopropyl 6-cyano-5-methoxycarbonyl-2-methyl-4-(3-nitrophenyl)-1,4-dihydro-pyridine-3-carboxylate-and process for the preparation thereof | |
| NO170581C (no) | Fremgangsmaate for fremstilling av vannfritt, krystallinsknatriumsalt av 5-klor-3-(2-tenoyl)-2-oksindol-1-karboksamid | |
| FI930191A0 (fi) | Inhibering av bindning av mac-1-receptorn till fibrinogen med anvaendning av d -homologer | |
| FI890028A0 (fi) | Menetelmä 2-substituoitujen adenosiinijohdannaisten valmistamiseksi | |
| ZA894302B (en) | Process for the preparation of granules | |
| AU3475189A (en) | Dry compositions for controlled release dosage forms | |
| FI91961C (fi) | Menetelmä (S)- -etyyli-2-okso-1-pyrrolidiiniasetamidin valmistamiseksi | |
| FI93106C (fi) | Menetelmä lääkeaineina käyttökelpoisten 2-iminobentsotiatsoliinijohdannaisten valmistamiseksi | |
| FI895983A0 (fi) | Menetelmä lääkeaineina käyttökelpoisten 2-bentsotiatsoliinijohdannaisten valmistamiseksi | |
| IL96916A0 (en) | Preparation of controlled release granules | |
| PH24958A (en) | Process for the preparation of resin-coated,non-sorptive,granular,pesticidal compositions | |
| EG19994A (en) | Process for the preparation of prolonged release composition based on trimebutine | |
| NO942218D0 (no) | Fremgangsmåte for fremstilling av karbonatsammensetning | |
| IL88847A0 (en) | Agents containing benzimidazole derivatives for promoting the yield of animals,certain such novel compounds and their preparation | |
| DE3470546D1 (en) | Process for the preparation of dry polycaprolactam granules | |
| DK367388D0 (da) | Til fremstilling af hoejredrejende 3-(3-pyridyl)-1h,3h-pyrrolo(1,2-c)thiazol-7-carboxylsyre | |
| FI91069B (fi) | Menetelmä 5-C-hydroksimetyylialdoheksoosipohjaisten yhdisteiden valmistamiseksi | |
| GB8405085D0 (en) | Controlled release formulation | |
| FI93008B (fi) | Menetelmä bakteerien vastaisten 6-fluori-1,4-dihydrokinol-4-oni-3-karboksyylihappojohdannaisten valmistamiseksi | |
| NO172636C (no) | Fremgangsmaate for fremstilling av kalsiumcyanamid | |
| ZA893966B (en) | Controlled release composition | |
| GB2191398B (en) | Controlled release dihydrocodeine composition | |
| IE861214L (en) | Compositions for the preparation of micro-particles for¹prolonged release |